drugset / Trial / NCT00259610

Treatment of Early Aggressive Rheumatoid Arthritis (TEAR)

NCT00259610

RandomizedFactorialQuadruple-blindTreatment

Summary

The purpose of this study is to 1)to determine if it is better to treat all early RA patients with methotrexate in combination with hydroxychloroquine plus sulfasalazine or in combination with etanercept or reserve this treatment for patients who do not appropriately respond to methotrexate alone and 2) to determine which combination of methotrexate therapy is better

Timeline

Start
2004-05
Primary completion
2009-06
Completion
2009-06

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Etanercept Protein / enzyme biologic
Comparator Hydroxychloroquine Small molecule
Comparator Methotrexate Small molecule
Comparator Sulfasalazine Small molecule

Indications